List of Tables
Table 1. Global Respiratory Syncytial Virus Vaccine for Children Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Respiratory Syncytial Virus Vaccine for Children Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global Respiratory Syncytial Virus Vaccine for Children Market Competitive Situation by Manufacturers in 2023
Table 4. Global Respiratory Syncytial Virus Vaccine for Children Sales (Dose) of Key Manufacturers (2019-2024)
Table 5. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Respiratory Syncytial Virus Vaccine for Children Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Respiratory Syncytial Virus Vaccine for Children Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Respiratory Syncytial Virus Vaccine for Children Average Price (US$/Dose) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Respiratory Syncytial Virus Vaccine for Children, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Respiratory Syncytial Virus Vaccine for Children, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Respiratory Syncytial Virus Vaccine for Children, Product Type & Application
Table 12. Global Key Manufacturers of Respiratory Syncytial Virus Vaccine for Children, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Respiratory Syncytial Virus Vaccine for Children by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Respiratory Syncytial Virus Vaccine for Children as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Respiratory Syncytial Virus Vaccine for Children Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Respiratory Syncytial Virus Vaccine for Children Sales by Region (2019-2024) & (Dose)
Table 18. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region (2019-2024)
Table 19. Global Respiratory Syncytial Virus Vaccine for Children Sales by Region (2025-2030) & (Dose)
Table 20. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region (2025-2030)
Table 21. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Region (2019-2024)
Table 23. Global Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Region (2025-2030)
Table 25. North America Respiratory Syncytial Virus Vaccine for Children Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 27. North America Respiratory Syncytial Virus Vaccine for Children Sales by Country (2025-2030) & (Dose)
Table 28. North America Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 32. Europe Respiratory Syncytial Virus Vaccine for Children Sales by Country (2025-2030) & (Dose)
Table 33. Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Sales by Region (2019-2024) & (Dose)
Table 37. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Sales by Region (2025-2030) & (Dose)
Table 38. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Respiratory Syncytial Virus Vaccine for Children Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 42. Latin America Respiratory Syncytial Virus Vaccine for Children Sales by Country (2025-2030) & (Dose)
Table 43. Latin America Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Sales by Country (2019-2024) & (Dose)
Table 47. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Sales by Country (2025-2030) & (Dose)
Table 48. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Respiratory Syncytial Virus Vaccine for Children Sales (Dose) by Type (2019-2024)
Table 51. Global Respiratory Syncytial Virus Vaccine for Children Sales (Dose) by Type (2025-2030)
Table 52. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Type (2019-2024)
Table 53. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Type (2025-2030)
Table 54. Global Respiratory Syncytial Virus Vaccine for Children Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Respiratory Syncytial Virus Vaccine for Children Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Type (2019-2024)
Table 57. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Type (2025-2030)
Table 58. Global Respiratory Syncytial Virus Vaccine for Children Price (US$/Dose) by Type (2019-2024)
Table 59. Global Respiratory Syncytial Virus Vaccine for Children Price (US$/Dose) by Type (2025-2030)
Table 60. Global Respiratory Syncytial Virus Vaccine for Children Sales (Dose) by Application (2019-2024)
Table 61. Global Respiratory Syncytial Virus Vaccine for Children Sales (Dose) by Application (2025-2030)
Table 62. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2019-2024)
Table 63. Global Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Application (2025-2030)
Table 64. Global Respiratory Syncytial Virus Vaccine for Children Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Respiratory Syncytial Virus Vaccine for Children Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Application (2019-2024)
Table 67. Global Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Application (2025-2030)
Table 68. Global Respiratory Syncytial Virus Vaccine for Children Price (US$/Dose) by Application (2019-2024)
Table 69. Global Respiratory Syncytial Virus Vaccine for Children Price (US$/Dose) by Application (2025-2030)
Table 70. Moderna Company Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 73. Moderna Respiratory Syncytial Virus Vaccine for Children Product
Table 74. Moderna Recent Developments/Updates
Table 75. Sanofi Company Information
Table 76. Sanofi Description and Business Overview
Table 77. Sanofi Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 78. Sanofi Respiratory Syncytial Virus Vaccine for Children Product
Table 79. Sanofi Recent Developments/Updates
Table 80. Meissa Company Information
Table 81. Meissa Description and Business Overview
Table 82. Meissa Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 83. Meissa Respiratory Syncytial Virus Vaccine for Children Product
Table 84. Meissa Recent Developments/Updates
Table 85. Blue Lake Biotechnology Company Information
Table 86. Blue Lake Biotechnology Description and Business Overview
Table 87. Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 88. Blue Lake Biotechnology Respiratory Syncytial Virus Vaccine for Children Product
Table 89. Blue Lake Biotechnology Recent Developments/Updates
Table 90. Codagenix Company Information
Table 91. Codagenix Description and Business Overview
Table 92. Codagenix Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 93. Codagenix Respiratory Syncytial Virus Vaccine for Children Product
Table 94. Codagenix Recent Developments/Updates
Table 95. Novavax Company Information
Table 96. Novavax Description and Business Overview
Table 97. Novavax Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 98. Novavax Respiratory Syncytial Virus Vaccine for Children Product
Table 99. Novavax Recent Developments/Updates
Table 100. Pfizer Company Information
Table 101. Pfizer Description and Business Overview
Table 102. Pfizer Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 103. Pfizer Respiratory Syncytial Virus Vaccine for Children Product
Table 104. Pfizer Recent Developments/Updates
Table 105. Wits Health Consortium (Pty) Ltd Company Information
Table 106. Wits Health Consortium (Pty) Ltd Description and Business Overview
Table 107. Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 108. Wits Health Consortium (Pty) Ltd Respiratory Syncytial Virus Vaccine for Children Product
Table 109. Wits Health Consortium (Pty) Ltd Recent Developments/Updates
Table 110. Advaccine Company Information
Table 111. Advaccine Description and Business Overview
Table 112. Advaccine Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 113. Advaccine Respiratory Syncytial Virus Vaccine for Children Product
Table 114. Advaccine Recent Developments/Updates
Table 115. Clover Biopharma Company Information
Table 116. Clover Biopharma Description and Business Overview
Table 117. Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Sales (Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2019-2024)
Table 118. Clover Biopharma Respiratory Syncytial Virus Vaccine for Children Product
Table 119. Clover Biopharma Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Respiratory Syncytial Virus Vaccine for Children Distributors List
Table 123. Respiratory Syncytial Virus Vaccine for Children Customers List
Table 124. Respiratory Syncytial Virus Vaccine for Children Market Trends
Table 125. Respiratory Syncytial Virus Vaccine for Children Market Drivers
Table 126. Respiratory Syncytial Virus Vaccine for Children Market Challenges
Table 127. Respiratory Syncytial Virus Vaccine for Children Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Respiratory Syncytial Virus Vaccine for Children
Figure 2. Global Respiratory Syncytial Virus Vaccine for Children Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Respiratory Syncytial Virus Vaccine for Children Market Share by Type: 2023 & 2030
Figure 4. Recombinant Protein Vaccine Product Picture
Figure 5. Nucleic Acid Vaccine Product Picture
Figure 6. Others Product Picture
Figure 7. Global Respiratory Syncytial Virus Vaccine for Children Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global Respiratory Syncytial Virus Vaccine for Children Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Centers for Disease Control and Prevention
Figure 11. Others
Figure 12. Global Respiratory Syncytial Virus Vaccine for Children Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Respiratory Syncytial Virus Vaccine for Children Market Size (2019-2030) & (US$ Million)
Figure 14. Global Respiratory Syncytial Virus Vaccine for Children Sales (2019-2030) & (Dose)
Figure 15. Global Respiratory Syncytial Virus Vaccine for Children Average Price (US$/Dose) & (2019-2030)
Figure 16. Respiratory Syncytial Virus Vaccine for Children Report Years Considered
Figure 17. Respiratory Syncytial Virus Vaccine for Children Sales Share by Manufacturers in 2023
Figure 18. Global Respiratory Syncytial Virus Vaccine for Children Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest Respiratory Syncytial Virus Vaccine for Children Players: Market Share by Revenue in Respiratory Syncytial Virus Vaccine for Children in 2023
Figure 20. Respiratory Syncytial Virus Vaccine for Children Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global Respiratory Syncytial Virus Vaccine for Children Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2030)
Figure 23. North America Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2030)
Figure 24. United States Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2030)
Figure 27. Europe Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2030)
Figure 28. Germany Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Region (2019-2030)
Figure 35. China Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2030)
Figure 43. Mexico Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa Respiratory Syncytial Virus Vaccine for Children Revenue Market Share by Country (2019-2030)
Figure 49. Turkey Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE Respiratory Syncytial Virus Vaccine for Children Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of Respiratory Syncytial Virus Vaccine for Children by Type (2019-2030)
Figure 53. Global Revenue Market Share of Respiratory Syncytial Virus Vaccine for Children by Type (2019-2030)
Figure 54. Global Respiratory Syncytial Virus Vaccine for Children Price (US$/Dose) by Type (2019-2030)
Figure 55. Global Sales Market Share of Respiratory Syncytial Virus Vaccine for Children by Application (2019-2030)
Figure 56. Global Revenue Market Share of Respiratory Syncytial Virus Vaccine for Children by Application (2019-2030)
Figure 57. Global Respiratory Syncytial Virus Vaccine for Children Price (US$/Dose) by Application (2019-2030)
Figure 58. Respiratory Syncytial Virus Vaccine for Children Value Chain
Figure 59. Respiratory Syncytial Virus Vaccine for Children Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
